antibiotic resistance

Talicia U.S. Commercialization Launch Expands Reach

February 25, 2026 – Raleigh, North Carolina & Tel-Aviv, Israel RedHill Biopharma Ltd. has announced the full operational and...

By cGxPwire Editor
February 25, 2026

Bio-Pharma

Positive Zoliflodacin Phase 3 Data Published in The Lancet

LONDON, December 12, 2025 — Innoviva Specialty Therapeutics announced the publication of positive Phase 3 clinical results for zoliflodacin...

By cGxPwire Editor
December 12, 2025

Bio-Pharma

Armata Pharmaceuticals Launches Advanced cGMP Phage Plant

Los Angeles, California, November 10, 2025 — Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company pioneering bacteriophage (phage) therapeutics targeting...

By cGxPwire Editor
November 10, 2025

Bio-Pharma

Armata Announces Phase 2a Success for S. aureus Phage Therapy

Los Angeles, CA – October 22, 2025 — Armata Pharmaceuticals, Inc., a biotechnology company advancing bacteriophage-based therapeutics, announced positive...